Patrys Ltd
ASX:PAB
Patrys Ltd
Common Stock
Patrys Ltd
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Patrys Ltd
ASX:PAB
|
Common Stock
AU$85.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Immutep Ltd
ASX:IMM
|
Common Stock
AU$446.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
Mesoblast Ltd
ASX:MSB
|
Common Stock
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Common Stock
$537m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Common Stock
AU$169.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Common Stock
AU$446.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
See Also
What is Patrys Ltd's Common Stock?
Common Stock
85.7m
AUD
Based on the financial report for Dec 31, 2023, Patrys Ltd's Common Stock amounts to 85.7m AUD.
What is Patrys Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
4%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Patrys Ltd have been 3% over the past three years , 5% over the past five years , and 4% over the past ten years .